1. Home
  2. LINC vs SAGE Comparison

LINC vs SAGE Comparison

Compare LINC & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LINC
  • SAGE
  • Stock Information
  • Founded
  • LINC 1946
  • SAGE 2010
  • Country
  • LINC United States
  • SAGE United States
  • Employees
  • LINC N/A
  • SAGE N/A
  • Industry
  • LINC Other Consumer Services
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • LINC Real Estate
  • SAGE Health Care
  • Exchange
  • LINC Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • LINC 499.3M
  • SAGE 462.2M
  • IPO Year
  • LINC 2005
  • SAGE 2014
  • Fundamental
  • Price
  • LINC $16.20
  • SAGE $6.94
  • Analyst Decision
  • LINC Strong Buy
  • SAGE Hold
  • Analyst Count
  • LINC 4
  • SAGE 20
  • Target Price
  • LINC $18.00
  • SAGE $11.39
  • AVG Volume (30 Days)
  • LINC 170.1K
  • SAGE 2.8M
  • Earning Date
  • LINC 02-24-2025
  • SAGE 02-12-2025
  • Dividend Yield
  • LINC N/A
  • SAGE N/A
  • EPS Growth
  • LINC N/A
  • SAGE N/A
  • EPS
  • LINC 0.32
  • SAGE N/A
  • Revenue
  • LINC $423,213,000.00
  • SAGE $106,399,000.00
  • Revenue This Year
  • LINC $16.43
  • SAGE N/A
  • Revenue Next Year
  • LINC $8.66
  • SAGE $122.32
  • P/E Ratio
  • LINC $50.43
  • SAGE N/A
  • Revenue Growth
  • LINC 15.21
  • SAGE 837.60
  • 52 Week Low
  • LINC $8.91
  • SAGE $4.62
  • 52 Week High
  • LINC $18.74
  • SAGE $27.68
  • Technical
  • Relative Strength Index (RSI)
  • LINC 59.69
  • SAGE 60.28
  • Support Level
  • LINC $14.31
  • SAGE $6.75
  • Resistance Level
  • LINC $15.54
  • SAGE $7.88
  • Average True Range (ATR)
  • LINC 0.52
  • SAGE 0.38
  • MACD
  • LINC 0.09
  • SAGE 0.13
  • Stochastic Oscillator
  • LINC 98.44
  • SAGE 64.39

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services and business and information technology. Its reportable segments include; Campus Operations, and Transitional. Majority of the revenue is generated from Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: